The landscape for the life sciences industry is changing. The COVID-19 pandemic, Brexit and the increasingly volatile geopolitical situation relating to the war in Ukraine are influencing the ability ...
The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...
Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results